多重耐药
P-糖蛋白
长春花
运输机
ATP结合盒运输机
体内
药理学
抗药性
生物
药品
计算生物学
基因
遗传学
作者
Katalin Goda,Zsolt Bacsó,Gábor Szabó
出处
期刊:Current Cancer Drug Targets
[Bentham Science]
日期:2009-05-01
卷期号:9 (3): 281-297
被引量:107
标识
DOI:10.2174/156800909788166493
摘要
P-glycoprotein (Pgp), coded for by the mdr1 gene, is one of the ABC transporters held responsible for the phenomenon of multidrug resistance (mdr), which is reflected by a rapidly escalating failure of chemotherapy with different classes of cytotoxic agents: anthracyclins, vinca alkaloids, taxanes, epipodophylotoxins. Although overcoming resistance conveyed by Pgp alone may not be sufficient for reaching effective treatment, the abundance of observations available for this paradigmatic multidrug transporter at both in vitro and in vivo setting is a tempting ground for an updated assessment of the main currents of mdr research. In this review we attempt to help keep track of the features of Pgp-mediated drug transport that serve as the major starting points for ongoing efforts of mdr reversal. We will analyze the slowly narrowing gaps that prevail between our ever increasing understanding at the protein, cell and organism level, focusing on the molecular interactions involving Pgp. Keywords: P-glycoprotein, multidrug resistance, hydrophobicity, membrane microdomains
科研通智能强力驱动
Strongly Powered by AbleSci AI